The medicinal chemistry of Chikungunya virus

EF da Silva-Júnior, GO Leoncini, ÉES Rodrigues… - Bioorganic & Medicinal …, 2017 - Elsevier
Arthropod-borne viruses (arboviruses) are an important threat to human and animal health
globally. Among these, zoonotic diseases account for billions of cases of human illness and …

PKC-theta in regulatory and effector T-cell functions

V Brezar, WJ Tu, N Seddiki - Frontiers in immunology, 2015 - frontiersin.org
One of the major goals in immunology research is to understand the regulatory mechanisms
that underpin the rapid switch on/off of robust and efficient effector (Teffs) or regulatory …

IL-7 induces SAMHD1 phosphorylation in CD4+ T lymphocytes, improving early steps of HIV-1 life cycle

M Coiras, M Bermejo, B Descours, E Mateos… - Cell reports, 2016 - cell.com
HIV-1 post-integration latency in CD4+ lymphocytes is responsible for viral persistence
despite treatment, but mechanisms involved in the establishment of latent viral reservoirs are …

Dasatinib inhibits HIV-1 replication through the interference of SAMHD1 phosphorylation in CD4+ T cells

M Bermejo, MR López-Huertas, J García-Pérez… - Biochemical …, 2016 - Elsevier
Massive activation of infected CD4+ T cells during acute HIV-1 infection leads to reservoir
seeding and T-cell destruction. During T-cell activation, the antiviral effect of the innate factor …

The CCR5-antagonist Maraviroc reverses HIV-1 latency in vitro alone or in combination with the PKC-agonist Bryostatin-1

MR López-Huertas, L Jiménez-Tormo… - Scientific reports, 2017 - nature.com
A potential strategy to cure HIV-1 infection is to use latency reversing agents (LRAs) to
eliminate latent reservoirs established in resting CD4+ T (rCD4+) cells. As no drug has been …

Epigenetic landscape in the kick-and-kill therapeutic vaccine BCN02 clinical trial is associated with antiretroviral treatment interruption (ATI) outcome

B Oriol-Tordera, A Esteve-Codina, M Berdasco… - …, 2022 - thelancet.com
Background The BCN02-trial combined therapeutic vaccination with a viral latency reversing
agent (romidepsin, RMD) in HIV-1-infected individuals and included a monitored …

Macrocyclic diterpenoids from euphorbiaceae as a source of potent and selective inhibitors of chikungunya virus replication

S Remy, M Litaudon - Molecules, 2019 - mdpi.com
Macrocyclic diterpenoids produced by plants of the Euphorbiaceae family are of
considerable interest due to their high structural diversity; and their therapeutically relevant …

Intracellular delivery of anti-pPKCθ (Thr538) via protein transduction domain mimics for immunomodulation

EI Ozay, G Gonzalez-Perez, JA Torres… - Molecular Therapy, 2016 - cell.com
Targeting cellular proteins with antibodies, to better understand cellular signaling pathways
in the context of disease modulation, is a fast-growing area of investigation. Humanized …

PKC phosphorylates HEXIM1 and regulates P-TEFb activity

K Fujinaga, M Barboric, Q Li, Z Luo… - Nucleic acids …, 2012 - academic.oup.com
The positive transcription elongation factor b (P-TEFb) regulates RNA polymerase II
elongation. In cells, P-TEFb partitions between small active and larger inactive states. In the …

Protein kinases C as potential host targets for the inhibition of chikungunya virus replication

R Abdelnabi, SN Amrun, LFP Ng, P Leyssen, J Neyts… - Antiviral Research, 2017 - Elsevier
We have shown previously that prostratin, a non-tumor promoting phorbol ester, inhibits
chikungunya virus (CHIKV)-induced cytopathic effects in vitro. Prostratin is a potent activator …